Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

P53-dependent and -independent links between DNA-damage, apoptosis and mutation frequency in ES cells

Abstract

The hypothesis that p53 deficiency enhances the survival of DNA-damage bearing cells was investigated in wild-type and p53 mutant embryonic stem (ES) cells. Following UV-C irradiation, p53 is rapidly induced in wild-type cells and p53-dependent apoptosis follows within 8 h, resulting in the death of the majority of cells within 36 h. Increasing doses of UV-irradiation resulted in enhanced clonogenic survival of null cells as compared to wild-type. Amongst surviving clones, the Hprt mutation frequency was found to be dependent upon UV dose and influenced by p53 status. Treatment with ionizing radiation led to enhanced expression of p53 but resulted in little induction of apoptosis irrespective of p53 status. However, clonogenic potential was considerably reduced, particularly in wild-type cells which showed a tenfold lower survival than null cells. In contrast to the effects of UV-irradiation, the incidence of Hprt mutation did not differ significantly between wild-type and p53 null survivors. The data confirm that p53 restricts the numbers of cells bearing mutations that survive DNA damage induced by either agent, albeit by different mechanisms.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8

Similar content being viewed by others

References

  • Aladjem MI, Spike BT, Rodewald LW, Hope MK, Jaenisch R and Wahl GM. . 1998 Curr. Biol. 8: 145–155.

  • Armstrong JF, Kaufman MH, Harrison DH and Clarke AR. . 1995 Curr. Biol. 5: 931–936.

  • Bakalkin G, Yakoleva T, Selivanova G, Kristinn P, Magnusson KP, Szekely L, Kiseleva E, Klein G, Terenius L and Wiman KG. . 1994 Proc. Natl. Acad. Sci. USA 91: 413–417.

  • Bischoff FZ, Yim SO, Pathak S, Grant G, Siciliano MJ, Giovanella BC, Strong SC and Tainsky MA. . 1990 Cancer Res. 50: 7979–7984.

  • Bouffler SD, Kemp CJ, Balmain A and Cox R. . 1995 Cancer Res. 55: 3883–3889.

  • Brain R and Jenkins JR. . 1994 Oncogene 9: 1775–1780.

  • Canman CE, Gilmer TM, Coutts SB and Kastan MB. . 1995 Genes Dev. 9: 600–611.

  • Carder P, Wyllie AH, Purdie CA, Morris RG, White S, Piris J and Bird CC. . 1993 Oncogene 8: 1397–1401.

  • Clarke AR, Cummings MC and Harrison DJ. . 1995 Oncogene 11: 1913–1920.

  • Clarke AR, Gledhill S, Hooper ML, Bird CC and Wyllie AH. . 1994 Oncogene 9: 1767–1773.

  • Clarke AR, Howard LA, Harrison DJ and Winton DJ. . 1997 Oncogene 14: 2015–2018.

  • Clarke AR, Purdie CA, Harrison DJ, Morris RG, Bird CC, Hooper ML and Wyllie AH. . 1993 Nature 362: 849–851.

  • Clutton SM, Townsend KMS, Goodhead DT, Ansell JD and Wright EG. . 1996 Cell Death Diff. 3: 141–148.

  • Crolla JA, Brown D and Whittingham DG. . 1990 Genet. Res. 55: 107–110.

  • Donehower LA, Godley LA, Aldaz CM, Shi Y, Pinkel D, Gray J, Bradley A, Medina D and Varmus HE. . 1995 Genes Dev. 9: 882–895.

  • Donehower LA, Harvey M, Slagle BL, McArthur MJ, Montgomery CA, Butel JS and Bradley A. . 1992 Nature 356: 215–221.

  • Fantes JA, Bickmore WA, Fletcher JM, Ballesta F, Hanson IM and van Heyningen V. . 1992 Am. J. Hum. Genet. 51: 1286–1294.

  • Fritsche M, Haessler C and Brandner G. . 1993 Oncogene 8: 307–318.

  • Fukasawa K, Wiener F, Vande Woude GF and Mai S. . 1997 Oncogene 15: 1295–1303.

  • Graeber TG, Peterson JF, Tsai M, Monica K, Fornace AJ and Giaccia AJ. . 1994 Mol. Cell. Biol. 14: 6264–6277.

  • Harvey M, Sands AT, Weiss RS, Hegi ME, Wiseman RW, Pantazis P, Giovanella BC, Tainsky MA, Bradley A and Donehower LA. . 1993 Oncogene 8: 2457–2467.

  • Hollstein M, Rice K, Greenblatt MS, Soussi T, Fuchs R, Sorlie T, Hovig E, Smith-Sorensen B, Montesano R and Harris CC. . 1994 Nucl. Acids. Res. 22: 3551–3555.

  • Hooper ML, Hardy K, Handyside A, Hunter S and Monk M. . 1987 Nature 326: 292–295.

  • Jacks T, Remington L, Williams BO, Schmitt EM, Halachmi S, Bronson RT and Weinberg RA. . 1994 Curr. Biol. 4: 1–7.

  • Kastan MB, Onyekwere O, Sidransky D, Vogelstein B and Craig RW. . 1981 Cancer Res. 51: 6304–6311.

  • Kuerbitz SJ, Plunkett BS, Walsh WV and Kastan MB. . 1992 Proc. Natl. Acad. Sci. USA 89: 7491–7495.

  • Langley RE, Palayoor ST, Coleman CN and Bump EA. . 1994 Int. J. Radiat. Biol. 65: 605–610.

  • Lane D. . 1992 Nature 358: 15–16.

  • Lee S, Elenbaas B, Levine A and Griffith J. . 1995 Cell 81: 1013–1020.

  • Leveillard T, Andera L, Bissonette N, Schaeffer L, Bracco L, Egly JM and Waslyk B. . 1996 EMBO J. 15: 1615–1624.

  • Li G, Mitchell DC, Ho VC, Reed JC and Tron VA. . 1996 Am. J. Path. 148: 1113–1123.

  • Li R, Waga S, Hannon GJ, Beach D and Stillman B. . 1994 Nature 371: 534–537.

  • Linke SP, Clarkin KC and Wahl GM. . 1997 Cancer Res. 57: 1171–1179.

  • Livingstone LR, White A, Sprouse J, Livanos E, Jacks T and Tlsty TD. . 1992 Cell 70: 923–935.

  • Lowe SW, Schmitt EM, Smith SW, Osborne BA and Jacks T. . 1993 Nature 362: 847–849.

  • Lu X and Lane D. . 1993 Cell 75: 765–778.

  • Magin TM, McWhir J and Melton DW. . 1992 Nucl. Acid Res. 20: 3795–3796.

  • Mahmud K, Shivi K, Kenny MK and Wood RD. . 1992 Cell 69: 367–374.

  • Malcomson RDG, Oren M, Wyllie AH and Harrison DJ. . 1995 Br. J. Cancer 72: 952–957.

  • Midgley CA, Owens B, Briscoe CV, Thomas DB, Lane DP and Hall PA. . 1995 J. Cell. Sci. 108: 1843–1848.

  • McBurney MW. . 1976 J. Cell. Physiol. 89: 441–455.

  • McBurney MW and Rogers BJ. . 1982 Dev. Biol. 89: 503–508.

  • Meling GI, Lothe RA, Borresen AL, Hauge S, Clausen OPF and Rognum TO. . 1993 Br. J. Cancer 67: 93–98.

  • Mortensen RM, Conner DA, Chao S, Geisterfer-Lowrance AAT and Seidman JG. . 1992 Mol. Cell. Biol. 12: 2391–2395.

  • Mountford P, Zevnik B, Düwel A, Nichols J, Li M, Dani C, Robertson M, Chambers I and Smith A. . 1994 Proc. Natl. Acad. Sci. USA 91: 4303–4307.

  • Mummenbrauer T, Janus F, Muller B, Wiesmuller L, Deppert W and Grosse F. . 1996 Cell 85: 1089–1099.

  • Nishino H, Knöll A, Buettner VL, Frish CS, Maruta Y, Haavik J and Sommer SS. . 1995 Oncogene 11: 263–270.

  • Prelich G, Kostura M, Mathews MB and Stillman B. . 1987 Nature 326: 471–475.

  • Purdie CA, Harrison DJ, Peter A, Dobbie L, White S, Howie SEM, Salter DM, Bird CC, Wyllie AH, Hooper ML and Clarke AR. . 1994 Oncogene 9: 603–609.

  • Rafferty JA, Clarke AR, Sellappan D, Koref MS, Frayling M and Margison GP. . 1996 Oncogene 12: 693–697.

  • Renzing J and Lane D. . 1995 Oncogene 10: 1865–1868.

  • Robertson E. . 1987 In: Teratocarcinomas and embryonic stem cells: A practical approach. Robertson E (ed.).. IRL Press: Oxford. pp.71–112.

    Google Scholar 

  • Robertson EJ and Bradley A. . 1986 In: Experimental approaches to mammalian embryonic development. Rossant J and Pederson RA (eds).. Cambridge University Press: Cambridge. pp.475–508.

    Google Scholar 

  • Sabapathy K, Klemm M, Jaenisch R and Wagner EF. . 1997 EMBO J. 16: 6217–6229.

  • Sah VP, Attardi LD, Mulligan GJ, Williams BO, Bronson RT and Jacks T. . 1995 Nature, Genet. 10: 175–180.

  • Sands AT, Suraokar MB, Sanchez A, Marth JE, Donehower LA and Bradley A. . 1995 Proc. Natl. Acad. Sci. USA 92: 8517–8521.

  • Schaefer L, Roy R, Humbert S, Moncollin V, Vermeulen W, Hoeijmakers JH, Chambon P and Egly JM. . 1993 Science 260: 58–63.

  • Scherer SJ, Welter C, Zang KD and Dooley S. . 1996 Biochem. Biophys. Res. Comm. 221: 722–728.

  • Seymour C and Mothersill C. . 1992 Mutation Res. 267: 19–30.

  • Smith ML, Chen I-T, Zhan Q, Bae I, Chen C-Y, Gilmer TM, Kastan MB, O'Connor PM and Fornace AJ. . 1994 Science 266: 1376–1322.

  • Smith ML, Chen I-T, Zhan Q, O'Connor PM and Fornace AJ. . 1995 Oncogene 10: 1053–1059.

  • Strasser A, Harris AW, Jacks T and Cory S. . 1994 Cell 79: 329–339.

  • Sturzbecher HW, Donzelmann B, Henning W, Knippschild U and Buchhop S. . 1996 EMBO J. 15: 1992–2002.

  • Sugano T, Nitta M, Ohmori H and Amaizumi M. . 1995 Jpn. J. Cancer Res. 86: 415–418.

  • Tsukada T, Tomooka Y, Takai S, Ueda Y, Nishikawa S, Yagi T, Tokunaga T, Takeda N, Suda Y, Abe S, Matsuo I, Ikawa Y and Aizawa S. . 1993 Oncogene 8: 3313–3322.

  • Vindelov LL, Christensen IJ and Nissen NI. . 1983 Cytometry 3: 323–327.

  • Wang XW, Yeh H, Schaeffer L, Roy R, Moncollin V, Egly J-M, Wang Z, Friedberg EC, Evans MK, Taffe BG, Bohr VA, Weeda G, Hoeijmakers JHJ, Forrester K and Harris CC. . 1995 Nature Genet. 10: 188–195.

  • Waga S, Hannon GJ, Beach D and Stillman B. . 1994 Nature 369: 574–578.

  • Yin Y, Tainsky MA, Bischoff FZ, Strong LC and Wahl GM. . 1992 Cell 70: 937–948.

  • Yonish-Rouach E, Resnitzky D, Lotem J, Sachs L, Kimchi A and Oren M. . 1991 Nature 352: 345–347.

  • Ziegler A, Jonason AS, Leffell DJ, Simon JA, Sharma HW, Kimmelman J, Remington L, Jacks T and Brash DE. . 1994 Nature 372: 773–776.

Download references

Acknowledgements

We thank J Lauder and R Speed for technical assistance. This work was supported by programme grants from the Cancer Research Campaign. ARC is a Royal Society University Research Fellow.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Corbet, S., Clarke, A., Gledhill, S. et al. P53-dependent and -independent links between DNA-damage, apoptosis and mutation frequency in ES cells. Oncogene 18, 1537–1544 (1999). https://doi.org/10.1038/sj.onc.1202436

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1202436

Keywords

This article is cited by

Search

Quick links